Silo Pharma, Inc. SEC filings SILO
Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Jul 31, 2026 | — |
| S-3 | Shelf registration | Jul 24, 2026 | — |
| 424B3 | Prospectus | Apr 16, 2026 | — |
| 424B3 | Prospectus | Apr 14, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 14, 2026 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Apr 10, 2026 | — |
| 424B3 | Prospectus | Nov 26, 2025 | — |
| S-1 | Registration statement | Oct 29, 2025 | — |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| 424B4 | Prospectus | May 16, 2025 | — |
| S-1/A | Amended registration statement | May 9, 2025 | — |
| S-1/A | Amended registration statement | Apr 29, 2025 | — |
| S-1 | Registration statement | Apr 25, 2025 | — |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| POS AM | Post-effective amendment to form s-1 | Mar 28, 2025 | — |
| 424B3 | Prospectus | Sep 4, 2024 | — |
| S-1 | Registration statement | Aug 21, 2024 | — |
| 424B3 | Prospectus | Jul 31, 2024 | — |
| S-1/A | Amended registration statement | Jul 25, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| S-1 | Registration statement | Jul 17, 2024 | — |
| 424B5 | Prospectus supplement | Jun 6, 2024 | — |
| S-3/A | Amendment no. 1 to form s-3 | Jan 25, 2024 | — |
| S-3 | Shelf registration | Jan 23, 2024 | — |
| 424B4 | Prospectus | Sep 28, 2022 | — |
| S-1/A | Amended registration statement | Sep 20, 2022 | — |
| S-1/A | Amended registration statement | Sep 9, 2022 | — |
| S-1/A | Amended registration statement | Aug 29, 2022 | — |
| S-1/A | Amended registration statement | Jul 25, 2022 | — |
| S-1 | Registration statement | Dec 7, 2021 | — |
| 424B3 | Prospectus | Apr 13, 2021 | — |
| S-1/A | Amended registration statement | Apr 7, 2021 | — |
| S-1 | Registration statement | Feb 16, 2021 | — |
| 424B3 | Prospectus | Oct 20, 2020 | — |
| 424B3 | Prospectus | Jun 8, 2020 | — |
| S-1 | Registration statement | May 22, 2020 | — |
| 424B3 | Prospectus | Jul 21, 2011 | — |
| S-1/A | Amended registration statement | Jun 28, 2011 | — |
| S-1/A | Amended registration statement | Jun 7, 2011 | — |
| S-1/A | Amended registration statement | May 11, 2011 | — |
| S-1 | Registration statement | Mar 30, 2011 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SILO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514183
- Former names
- Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.